Mismatch repair (MMR)-deficient cells are shown to produce >15-fold more methotrexate-resistant colonies than MMR normal cells. The increased resistance to methotrexate is primarily due to gene amplification since all the resistant clones contain double-minute chromosomes and increased copy numbers of the DHFR gene. In addition, integration of linearized or retroviral DNAs into chromosomes is also significantly elevated in MMR-deficient cells. These results suggest that in addition to microsatellite instability and homeologous recombination, MMR is also involved in suppression of other genome instabilities such as gene amplification and chromosomal DNA integration.
INTRODUCTION
Mismatch repair (MMR) has been shown to suppress both microsatellite instability and homeologous recombination (reviewed in 1-3). In the current study, we have investigated whether MMR is also involved in suppression of other genomic instabilities such as gene amplification and chromosomal DNA integration.
Gene amplification occurs during the development of many organisms (4), emergence of drug resistance (5) and progression of cancer (5) (6) (7) . Amplified genes are often found to organize as giant inverted repeats in the forms of either circular inverted dimers (e.g. double-minute chromosomes) (8) (9) (10) or head-to-head linear arrays (e.g. homogeneous staining region) (11) . It was proposed that generation of DNA fragments with free ends (generated through over-replication or during excision of the replication bubble) could be the initiation event during gene amplification process(es) (5, 12) . Subsequent processing of these linear DNA fragments can lead to the formation of extrachromosomal circular DNA as the gene amplification product. There are different ways that the linear DNA with free ends can be processed. It is generally accepted that non-homologous end joining (NHEJ) is the major mechanism responsible for the repair of DNA double-stranded breaks (13) . DNA replication prior to double-strand breaks (excision of the replication bubble) or after the excision of the linear DNA fragment from chromosome can produce a pair of identical linear DNAs with their quasi-identical ends located in close proximity spatially. Joining of these ends through NHEJ will lead to the production of an extrachromosomal circular DNA with giant inverted duplications (inverted dimer) separated by two unique junctions. NHEJ is the essential step of breakage-fusion-bridge cycles proposed to explain the formation of homogeneous staining region (11) . This mechanism is also used to explain the formation of the homogeneous staining region (HSR) during gene amplification in hamster cells (14, 15) .
We show that MMR-deficient cells exhibit increased drug resistance frequencies toward methotrexate (MTX). Analysis of MTX-resistant colonies has indicated the presence of double-minute chromosomes and amplification of the DHFR gene. The frequencies of chromosomal DNA integration as assayed by both transfection of linear DNAs and retroviral integration were also increased significantly in MMR-deficient cells. These results suggest that the MMR system can suppress both gene amplification and chromosomal DNA integration.
MATERIALS AND METHODS

Cell lines
HCT116+Ch2 (MMR -) and HCT116+Ch3 (MMR + ) cell lines, which were derived from HCT116 (human colorectal carcinoma with hMLH1 -/-) cells, were obtained from Dr C. R. Boland (University of California at San Diego, CA) (16) . Plasmid pC9MLHWT (gift from Dr B. Vogelstein, Johns Hopkins Oncology Center, MD), which harbors the wild-type hMLH1 cDNA (under the control of CMV promoter), was used to transfect HCT116 cells by electroporation and the resulting G418-resistant clone which expressed the hMLH1 protein was termed HCT116+hMLH1. DLD-1+Ch2 (MMR + ) and HEC59+Ch2 (MMR + ) cell lines and their respective MMRdeficient mutant cell lines, DLD-1 (hMSH6 -) and HEC59 (hMSH2 -), were provided by Dr Thomas A. Kunkel (National Institute of Environmental Health Sciences, NC) (17, 18) . Cells were cultured in complete RPMI medium supplemented with 10% fetal bovine serum. DLD-1+Ch2, HEC59+Ch2, HCT116+Ch2 and HCT116+Ch3 were cultured in the presence of 400 µg/ml of G418. HCT116+hMLH1 cells were cultured in the presence of 100 µg/ml of G418.
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Single step gene amplification test
Subconfluent cells (2.5 × 10 6 ) were seeded in 100 × 20 mm culture dishes with complete RPMI-1640 medium supplemented with 10% commercially dialyzed fetal bovine serum (Gibco) 24 h prior to drug selection. Following medium change, MTX was added (14 × IC 50 ) to each plate and the plates were incubated in a 37°C incubator supplied with 5% CO 2 . Depending on the growth of the cells, as judged by the color of the medium, cells were replenished with fresh medium in the presence of continuous MTX selection. Colonies were either picked or stained with methylene blue after 1 month of growth. The plating efficiency of cell lines was determined by seeding 100 cells in 100 × 20 mm culture dishes and counting the colonies after 10 days of growth.
DHFR gene copy number analysis
Genomic DNAs were isolated from 2 × 10 6 MTX r or parental cells. Cells were pelleted and lysed in 1 ml of lysis buffer (25 mM Tris-HCl pH 8.0, 25 mM EDTA, 1% SDS, 0.5 mg/ml proteinase K). Cell lysates were incubated at 50°C overnight. Following ethanol precipitation and resuspension, RNaseA was added to 100 µg/ml and the mixture was kept at 37°C for 30 min. After phenol extraction (twice), DNAs were precipitated with 0.1 vol 3 M NaOAc and 2 vol ethanol. DNA pellets were washed once with 70% ethanol, air-dried and resuspended in 50 µl of TE buffer. Upon digestion with EcoRI restriction enzyme, the 1.8 kb genomic DNA fragment containing part of the DHFR gene was detected by Southern hybridization analysis using the 32 P-labeled DHFR genomic DNA probe.
Analysis of metaphase chromosomes
Cells (2 × 10 4 ) were seeded on 100 × 20 mm dishes. After 48 h, cells were replenished with fresh medium followed by addition of colcemid (Sigma) (400 µg/ml). Following incubation at 37°C for 10-15 h, cells were dislodged from dishes by trypsin-EDTA. Cells were collected by centrifugation at 100 g for 5 min and then resuspended in 5 ml of a hypotonic solution (0.04 M KCl and 0.025 M sodium citrate) and incubated at 37°C for 20 min. An equal volume of ice-cold acetic acid/ methanol (1:3) was added to the cell mixture. Cells were pelleted and resuspended in 5 ml of acetic acid/methanol and incubated on ice for 10 min. Cell pellets were collected again after centrifugation for 2 min at 100 g and resuspended in 200 µl of ice-cold acetic methanol. The cell suspension (3 µl) was dropped onto a cold slide and the slide was quickly dried off on top of flame. The chromosome spread was mounted with mounting medium [0.1 M Tris, pH 9.2, 50% glycerol, 1 µg/ml p-phenylenediamine (Sigma), 1 µg/ml DAPI] and viewed under a fluorescence microscope.
Cytological immunostaining of hMLH1
Cells were grown on glass coverslips overnight. The cells were then fixed with the 50% acetone/50% methanol solution after washing with PBS. Immunostaining was performed following the manufacturer's instructions (Dako, CA). The fixed cells were incubated for 30 min at room temperature with antibodies against human hMLH1 (mAb G168-15, PharMingen, USA), dilution 1:50. Immuno-reactivity was detected using a twostep peroxidase detection system (Dako). Staining was evaluated under microscope after hematoxylin counterstain.
DNA transfection into mammalian cells
The linear DNA substrate used for transfection was generated by linearization of 100 µg of pTK-hygro (Clontech) with HindIII, followed by phenol/CHCl 3 extraction and ethanol precipitation. The linear DNA was purified from agarose gel after electrophoresis in Tris-acetate-EDTA buffer (TAE). Gel-purified linear DNA substrate (5 µg) was electroporated (500 µF and 400 V) into MMR-deficient cells (HCT116+Ch2, DLD-1 and HEC59) and MMR-proficient cells (HCT116+Ch3, DLD-1+Ch2 and HEC59+Ch2) using the Gene Pulser apparatus from Bio-Rad (Hercules, CA). Transfected cells were resuspended in RPMI-1640 plus 10% FBS and 400 µg/ml G418 after placing on ice for 10 min. Various concentrations of hygromycin B were added to transfected cells after 24-36 h. Cells were replenished with medium containing the selecting drugs (G418 and/or hygromycin B) every 3-4 days. The resistant colonies appeared after 3-4 weeks.
Integration assay with the infection of retroviruses
The packaging cell line GPGC/GIP that contains replication defective pseudo-type MMLV retroviruses was kindly provided by Dr Joseph P. Dougherty (Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, NJ). The replication defective pseudo-type MMLV retrovirus contains the puromycin-resistant marker gene (for integration selection). Viruses were collected from the medium of the packaging cells without any selection drugs. The retrovirus infection was performed in 50 µg/ml ploybrene (Sigma). Host cells (5 × 10 5 ) were infected with viruses at 37°C with 5% CO 2 for 40 min by rocking the dishes gently to redistribute the virus every 10 min. The polybrene solutions were then removed and replaced with fresh growth medium. Puromycin (10 or 50 µM; Sigma) was added after 24 h and cells were grown in puromycin for 10 days.
RESULTS
Mismatch repair (MMR)-deficient cells exhibit increased frequencies of gene amplification
The pathways (see Introduction) just described for gene amplification point out the requirement of homeologous recombination processes. MMR has been shown to suppress homeologous recombination in prokaryotic and eukaryotic cells (19, 20) . Thus only mutant cells defective in MMR are expected to be competent in these processes. We have tested whether MMR-deficient cells exhibit higher resistance frequencies toward MTX. Isogenic pairs of MMR + and MMRhuman cell lines were used. The HCT116 (human colorectal carcinoma) cell line is defective in MMR and has known microsatellite instability due to mutation in the hMLH1 locus. The same cell line has been transduced with chromosome 3 (carrying the wild-type hMLH1 gene), and the resulting 'revertant' cell line exhibits the MMR + phenotype (21) . The cell line (HCT116+Ch2) in which chromosome 2 has been transferred is a control and has the same phenotype as HCT116. As shown in Figure 1A and B, HCT116+Ch2 (MMR -) cells gave rise to >40-fold more MTX r colonies than HCT116+Ch3 (MMR + ) cells (Fig. 1A and B) . The parental cell line HCT116 also gave rise to ∼40-fold more MTX r colonies than HCT116+Ch3 cell line (Fig. 2B) . The IC 50 of MTX (Fig. 1C) for HCT116+Ch2 (MMR -) cells is ∼0.006 µM that is slightly lower than the IC 50 of MTX for HCT116 MMR -(0.009 µM) cells and HCT116+Ch3 MMR + (0.01 µM) cells, suggesting that the higher drug resistance frequency in hMLH1-deficient cells is not due to the difference in MTX sensitivity.
Amplification of the DHFR gene is known to be one major resistance mechanism to MTX (22) (23) (24) (25) (26) . In order to verify that MTX resistance in our system was indeed due to amplification of the DHFR gene, we determined the copy number of the DHFR gene in MTX r clones. The same amount of genomic DNAs isolated from parental and various MTX r cells was digested with EcoRI, and the digested DNA fragments were separated by gel electrophoresis. Southern hybridization was performed to determine the copy number of the DHFR gene using a 32 P-labeled 1.8 kb fragment of EcoRI-restricted DHFR genomic DNA as a probe. As shown in Figure 1D , the DHFR gene in every clone isolated from MTX r cells of HCT116+Ch2 was amplified (>4-fold). Microscopic examination of the resistant cells from several clones has also revealed the presence of multiple double-minute chromosomes (data not shown).
To further verify the role of hMLH1 and MMR system in suppression of gene amplification
In order to rule out the possibility that some unknown factors other than hMLH1 gene on chromosome 3 are responsible for the suppression of DHFR gene amplification in HCT116+Ch3 cells, we introduced the wild-type hMLH1 cDNA into cell line HCT116 (hMLH1 -/-). The expression of the hMLH1 cDNA was confirmed by immunostaining with monoclonal antihMLH1 antibody (Fig. 2A) . Mutant hMLH1 (homozygous mutation at codon 252) if expressed in HCT116 cannot be recognized by the same antibody ( Fig. 2A) . Again, HCT116 (MMR -) cells gave rise to ∼40-fold more MTX r colonies than HCT116+hMLH1 (MMR + ) cells (Fig. 2B) as that shown in Figure 1A and 1B.
To further verify the roles of MMR systems in the suppression of gene amplification, cell lines have mutations in other MMR genes and their chromosome complemented cell lines were chosen to perform MTX drug resistance test. The human endometrial tumor cell lines HEC59 (hMSH2 -) and HEC59+Ch2 (hMSH2 + ) and colon cancer cell lines DLD-1 (hMSH6 -) and DLD-1+Ch2 (hMSH6 + ) were used to test the effect of hMSH2 or hMSH6 mutation on DHFR gene amplification. Again, HEC59 and DLD-1 (MMR -) cells gave rise to 
MMR-deficient cells exhibit elevated frequencies of chromosomal DNA integration
Our MTX results suggest that MMR may be involved in suppression of gene amplification in mammalian cells. To determine whether MMR may also be involved in suppressing NHEJ that was proposed as a possible pathway for gene amplification (see Introduction), we have tested chromosomal DNA integration in MMR-deficient and MMR-proficient cells. Linear DNA (pTK-hyg restricted with HindIII) was transfected into MMR wild-type (HCT116+Ch3, DLD-1+Ch2 or HEC59+Ch2) and their respective mutant (HCT116+Ch2, DLD-1 or HEC59) cells. Results show an average of ∼15-fold higher transfection efficiency with MMR mutant cells (Fig. 3) . The chromosomal integration of linear DNA was determined by Southern analysis with 32 P-labeled pTK-hyg (data not shown).
MMR-deficient cells exhibit elevated frequency of retroviral integration
Integration of retroviral DNA into the host genome is part of the replication cycle of retroviruses (27) . The proposed preintegration structure, which is generated by the reaction of integrase, contains a 4-6-base gap and a 2-base mismatch at each end (28) . Thus, retroviral integration can also be considered as a type of non-homologous recombination. To test whether MMR also suppresses the integration of retroviral DNA, the amphotropic retroviruses were used to infect MMR -(HCT116+Ch2, DLD-1 or HEC59) and MMR + (HCT116+Ch3, DLD-1+Ch2 or HEC59+Ch2) human cells. Puromycin (10 or 50 µM) was used to select for integrants. As shown in Figure 4 , MMR-deficient mutant cells exhibited higher (average 4.2 ± 1.0-fold) integration frequency from four independent infection experiments (see Materials and Methods).
DISCUSSION
In this study, our results have clearly demonstrated that MMR suppresses DHFR gene amplification (Figs 1 and 2 ) and chromosomal DNA integration of the linear DNA in human cells (Fig. 3) . The mechanisms by which the DHFR gene is amplified and the linear DNA is integrated into the chromosome are not clear but may involve NHEJ processes (29, 30) .
We have also demonstrated that MMR suppresses retroviral integration (Fig. 4) . This result is quite unexpected since retroviral integration is primarily carried out by the integrase (IN)  (31,32) . The pre-integration complex contains two 4-6-base gaps with two 2-base flaps (28) . The cellular enzymes involved in processing this pre-integration complex are not known. However, it has been reported that retroviral integration is reduced in cells defective in repair of double-strand breaks (e.g. DNA-PK mutant cells) (33) . DNA-PK is known to be a key component of NHEJ (reviewed in [34] [35] [36] . The idea that DNA-PK is directly involved in integration processes and/or protects the cells from DNA breaks (a side-effect of integration) was proposed (28, 33) . Moreover, our results also suggest that retroviral integration could have overlapping steps with NHEJ that is suppressed by MMR as the assay of chromosomal integration of the linear DNA (Fig. 3) .
The detailed mechanism(s) for NHEJ remains elusive. Factors such as DNA ligase IV, Xrcc4, Ku70, Ku80(86) and DNA-PKcs have been shown to be required for NHEJ in vivo (37) (38) (39) (40) (41) (42) (43) (44) and in vitro (45) . End-joining appears to involve at least two pathways: the blunt end ligation that does not require pairing of bases and the joining of ends with single-stranded extensions that depends on short sequence homologies (29, 46) . Therefore, end-joining through pairing of short homologies could potentially generate an intermediate containing mismatches (i.e. a heteroduplex intermediate or DNA with protruding ends). Indeed, studies in yeast have suggested that Msh2p and Msh3p are involved in double-strand breakinduced recombination (47) . It was suggested that Msh2p and Msh3p are required to remove 3′ non-homologous DNA tails during genetic recombination initiated on non-homologous ends of a double-strand break (48) . It seems possible that some MMR proteins may be involved in certain aspects of NHEJ in mammalian cells as well. However, our results indicate that these MMR proteins could be involved in suppression rather than promotion of NHEJ.
MMR is known to suppress homeologous recombination in both prokaryotic and eukaryotic cells (19, 20) . Our previous studies have demonstrated that recombinational rearrangements mediated by imperfect inverted repeats, which do not involve the formation of a Holliday junction, are also suppressed by MMR (49) . It has been suggested that MMR suppresses homeologous recombination by aborting a heteroduplex recombinational intermediate (49) . One possible explanation for our results is that NHEJ may also involve the formation of a heteroduplex intermediate that is aborted/ destroyed by MMR. Consequently, MMR may suppress both gene amplification and chromosomal DNA integration by the same mechanism, i.e. aborting the putative heteroduplex intermediates.
Previous studies in the Escherichia coli system have shown that the giant circular inverted dimers, resembling the structure of some gene amplification products, can be generated via recombination/rearrangement mediated by small inverted repeats (49) (50) (51) . In this case, circular plasmid DNAs containing a pair of small inverted repeats were shown to mediate efficient recombination/rearrangement to produce circular inverted dimers. It remains unknown whether circular DNAs containing a pair of small inverted repeats could be the precursors of inverted duplications for gene amplification as we observed in E.coli. One argument is what the driving force will be to generate the inverted dimer from the circular monomer. Alternatively, and very likely, the circular inverted dimers are directly formed from linear chromosomes. Since there are abundant repetitive DNA sequences (e.g. human Alu sequences) in mammalian cells, the presence of one or even two pairs of inverted repeats in the region to be amplified should not present a problem. Indeed, studies of the amplified H-circles from drug-resistant Leishmania have demonstrated that the unamplified H-locus is bracketed by two pairs of inverted repeats of 198 and 1241 bp, respectively, one at each end of the H-locus (52, 53) . These two pairs of inverted repeats have been suggested to be crucial for the amplification of the H-circles (52, 53) . Our current studies further demonstrate that linear DNA constructs containing inverted repeats at each end can also give rise to circular inverted dimers in both mammalian cells and E.coli (54) . In addition, our results point to a model in which a dumbbell-like DNA intermediate, generated through nuclease/helicase processing of the linear DNA substrate, is responsible for the formation of the circular inverted dimer (54) .
Based on these studies, we propose the homeologous recombination processes including the NHEJ pathway (see Introduction) as well as a dumbbell model for gene amplification as shown in Figure 5 
